healthrx.com

Provigil (Modafinil) Cost in Tennessee: Prices, Insurance, and Savings in 2026

By
Updated
Prescription access and medication affordability image for Provigil (Modafinil) Cost in Tennessee: Prices, Insurance, and Savings in 2026
Image: HealthRX.com clinical image

Modafinil is the generic name for a wakefulness-promoting oral tablet sold under the brand name Provigil (Cephalon/Teva). It is FDA-approved for narcolepsy, as an adjunct treatment for excessive sleepiness related to obstructive sleep apnea, and for shift-work sleep disorder. It is a Schedule IV controlled substance under the Controlled Substances Act. Armodafinil (Nuvigil), a related but distinct molecule, is not covered on this page.

The useful question for a Tennessee patient is not "what does Provigil cost" but "which coverage lane applies to me." Brand-name Provigil, generic modafinil paid in cash, commercial insurance with prior authorization, TennCare, and 340B-eligible clinics each produce very different bills, and the gap between them is usually larger than any single average price quoted online. Because pharmacy cash prices, discount-card rates, and state Medicaid formulary decisions change over time and by location, this article separates what is stable (federal approval status, drug class, generic availability) from what a reader must verify at the point of care in 2026.

What is established, what needs verification

Established and stable: Modafinil has FDA approval for narcolepsy, OSA-related sleepiness (adjunct), and shift-work disorder. Generic modafinil has been available since patent expiration and FDA-approved generics are rated therapeutically equivalent to brand Provigil in the Orange Book (FDA Orange Book). Modafinil is Schedule IV. Compounding of modafinil by a licensed 503A pharmacy for a patient-specific prescription is generally understood to be legal under federal law when the compounded product is not essentially a copy of a commercially available drug.

Plausible but requiring current verification: The specific dollar amount a Tennessee patient pays in cash, through a discount card, through a commercial plan copay, or at a 340B pharmacy. These figures move with contract pricing, pharmacy chain, and time of year, and no single number is accurate for every pharmacy or every month of 2026.

Not established from the sources available for this article: TennCare's current preferred drug list status for modafinil, and any Tennessee-specific insurer prior-authorization template. General federal Medicaid rules require coverage of most FDA-approved drugs but give states discretion to manage utilization through preferred drug lists and clinical criteria (Medicaid Drug Rebate Program overview). Whether TennCare currently excludes modafinil, covers it with prior authorization, or covers it only for specific diagnosis codes is a state-level formulary fact that changes and must be confirmed directly with TennCare or a participating MCO rather than assumed from this article.

What modafinil actually costs

Generic modafinil is substantially less expensive than the brand-name Provigil list price nationally, and that gap is well documented in general drug-pricing literature, but exact current figures for Tennessee retail pharmacies are not verifiable from the sources behind this article. Readers should treat any specific number, including figures elsewhere on the internet quoting a fixed monthly price, as a snapshot that may be outdated by the time they fill a prescription. A pharmacy price-comparison tool, a call to a local pharmacy, or a discount-card app will give a more reliable current number than any published article.

There is no clinical reason to choose brand Provigil over an FDA-approved AB-rated generic. Brand-name list pricing for many long-marketed drugs stays elevated even after generics dominate the market, largely for reasons related to pharmacy benefit manager rebate structures rather than clinical necessity; this is a general market pattern, not a Tennessee-specific finding.

Does Tennessee Medicaid (TennCare) cover modafinil?

This is one of the most consequential questions for cost, and it is also the one where this article can offer the least certainty. TennCare, like other state Medicaid programs, sets its own preferred drug list and can apply clinical criteria to a drug even though federal rebate rules generally require coverage of FDA-approved products (Medicaid Drug Rebate Program). Whether modafinil is currently excluded, covered with prior authorization, or covered only for a narrow set of diagnosis codes on TennCare is a fact that changes and should be confirmed directly with TennCare or the enrollee's MCO before assuming either outcome. If a TennCare enrollee is denied coverage, a physician-initiated exception request that documents a confirmed diagnosis (polysomnography and MSLT-confirmed narcolepsy, or a documented shift-work schedule) is the standard appeal pathway, though approval is not guaranteed.

How commercial insurance typically handles modafinil

Commercial plans generally cover generic modafinil when a diagnosis matches an FDA-approved indication, and prior authorization is common. Insurers typically want documentation such as a sleep study for narcolepsy or a documented rotating/night-shift schedule for shift-work disorder before approving the drug. Some plans use step therapy, requiring a trial of a lower-cost stimulant first. The specific copay tier, prior-authorization form, and step-therapy rule differ by plan and by year, and readers should check their own plan's current formulary rather than rely on a generalized copay range, since those figures are volatile and not verifiable for every Tennessee plan from the sources behind this article.

Telehealth prescribing of modafinil in Tennessee

Tennessee permits telehealth prescribing of Schedule IV controlled substances, including modafinil, when the prescriber holds an active Tennessee medical license (or qualifies under the Interstate Medical Licensure Compact) and completes a real-time audiovisual evaluation. Federal controlled-substance telehealth rules, including flexibilities tied to the Ryan Haight Act framework, have shifted over recent years, so a patient or prescriber relying on a specific current telehealth rule should confirm the rule in effect at the time of the visit rather than assume a rule described in an earlier year still applies unchanged in 2026.

Is compounded modafinil legal in Tennessee?

Yes, in the sense that federal law permits a licensed 503A pharmacy to compound a drug for an individual patient with a valid prescription, provided the compounded product is not essentially a copy of a commercially available drug. In practice, compounding is rarely necessary for modafinil because commercial tablets are widely available at standard doses. Compounding may be considered for a non-standard dose, a documented excipient allergy, or a swallowing difficulty requiring a liquid formulation, and it should be discussed with the prescriber rather than requested independently. Insurance rarely covers compounded preparations, and compounded product pricing varies by pharmacy without a reliable published average.

Discount programs and 340B access

Pharmacy discount cards and coupon platforms can lower the cash price of generic modafinil at participating pharmacies, though the discount and eligible pharmacies change over time and cannot be quoted as a fixed number here. Patients who receive care at a federally qualified health center, Ryan White clinic, or another 340B-covered entity may have access to reduced-cost outpatient drugs through that entity's contract pharmacy, under the federal 340B Drug Pricing Program (HRSA 340B program). Whether a specific Tennessee clinic participates and what its current modafinil price is must be confirmed directly with that clinic.

Safety and monitoring considerations that affect the total cost of therapy

The FDA label for Provigil recommends monitoring for cardiovascular effects, including blood pressure and heart rate, particularly in patients with pre-existing cardiovascular disease. The label also warns that modafinil can reduce the effectiveness of hormonal contraceptives during use and for a period after discontinuation, because of an interaction with hepatic drug-metabolizing enzymes, and recommends an alternative or additional contraceptive method during that time (Provigil prescribing information). Modafinil has also been associated with rare but serious skin reactions, including Stevens-Johnson syndrome; a patient who develops a new rash while taking modafinil should stop the medication and seek prompt medical evaluation. These monitoring needs (an occasional office visit or blood pressure check) add a modest, variable cost to therapy beyond the pharmacy price, though a specific annual dollar estimate is not supported by verifiable sources for this article and has been removed rather than guessed.

Reported cardiovascular effect sizes and dermatologic incidence figures for modafinil vary across the literature. A reader who needs a precise number for clinical decision-making should ask their prescriber to reference the current FDA label and up-to-date primary literature rather than rely on any single number republished across cost-focused consumer articles, including earlier versions of this one.

Off-label use and coverage

Modafinil is prescribed off-label for conditions such as ADHD and fatigue related to multiple sclerosis or cancer treatment. The FDA has not approved modafinil for these uses, and Tennessee insurers, including TennCare and commercial plans, generally deny prior authorization when the diagnosis code does not match an FDA-approved indication for narcolepsy, shift-work disorder, or OSA. Evidence for off-label uses is mixed: reports in the literature on MS-related fatigue have not consistently shown a clear benefit over placebo, and pediatric ADHD data raised dermatologic safety concerns that contributed to the FDA declining a pediatric indication. Because these are specific trial findings, a clinician or patient who needs the exact study results for a treatment decision should ask a physician to pull the primary paper rather than rely on a secondhand citation, since the identifiers commonly circulated for these claims could not be independently verified for this article.

Verification checklist: what is stable vs. what changes

Use this checklist to separate facts that a reader can trust as durable federal or clinical facts from facts that must be re-checked at the pharmacy counter or with an insurer before assuming they apply in 2026.

Stable federal and clinical facts (unlikely to change year to year):

  • Modafinil's FDA-approved indications: narcolepsy, OSA-adjunct, shift-work disorder
  • Modafinil's DEA Schedule IV status
  • Generic modafinil's AB-rated therapeutic equivalence to brand Provigil (confirm current status in the FDA Orange Book)
  • The general legality of 503A compounding for patient-specific, non-copy preparations
  • The label's contraceptive-interaction warning and cardiovascular monitoring recommendation

Date-sensitive facts that require verification before relying on them:

  • The current cash price of generic modafinil at a specific Tennessee pharmacy this month
  • Whether TennCare currently covers, excludes, or restricts modafinil, and under what diagnosis codes (confirm directly with TennCare or the enrollee's MCO)
  • A specific commercial insurer's current prior-authorization form and step-therapy requirement
  • Whether a specific discount card or coupon platform currently offers a lower price at a specific pharmacy
  • Whether a specific Tennessee clinic is currently a 340B-covered entity and what its contract pharmacy charges (confirm with the clinic and HRSA's 340B program office)
  • Current DEA/federal telehealth flexibility rules for prescribing a Schedule IV drug without an in-person visit

How to verify: call the dispensing pharmacy directly, log into the insurance plan's member portal for the current formulary and prior-authorization criteria, and confirm TennCare status through TennCare's own published preferred drug list or member services rather than a third-party summary, including this one.

When to seek care instead of optimizing cost

Cost strategies should never delay urgent evaluation. A patient who develops a spreading rash, blistering, fever with rash, chest pain, an irregular heartbeat, or signs of an allergic reaction while taking modafinil should stop the medication and seek immediate medical care rather than trying to finish a prescription to avoid wasting money on it.

References

This article is drafted for editorial and qualified medical review and has not yet completed that review. It does not provide individualized dosing or coverage determinations. Confirm all current price, formulary, and coverage details directly with the pharmacy, insurer, or state Medicaid program before making a treatment decision.